Effects of berberine and barberry on anthropometric measures: A systematic review and meta-analysis of randomized controlled trials

被引:15
作者
Amini, Mohammad Reza [1 ,2 ]
Sheikhhossein, Fatemeh [3 ]
Naghshi, Sina [3 ]
Djafari, Farhang [1 ]
Askari, Mohammadreza [1 ]
Shahinfar, Hossein [1 ]
Safabakhsh, Maryam [1 ]
Jafari, Alireza [1 ]
Shab-Bidar, Sakineh [1 ]
机构
[1] Tehran Univ Med Sci, Sch Nutr Sci & Dietet, Dept Community Nutr, Tehran, Iran
[2] Tehran Univ Med Sci, SSRC, Tehran, Iran
[3] Tehran Univ Med Sci, Sch Nutr Sci & Dietet, Dept Clin Nutr, Tehran, Iran
关键词
Berberine; Barberry; Anthropometric; Randomized controlled trials; Meta-analysis; MARIANUM FIXED COMBINATION; LIPID PROFILE; METABOLIC SYNDROME; VULGARIS FRUIT; OBESITY; PREVALENCE; EXTRACT; STATINS; HEALTH; KINASE;
D O I
10.1016/j.ctim.2020.102337
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Objective: Despite controversies, no study has systematically summarized findings from earlier studies on the effect of berberine and barberry on anthropometric measures. Therefore, the current systematic review and meta-analysis was conducted on the effect of berberine and barberry on body mass index (BMI), body weight (BW), waist circumference (WC) and waist-hip ratio (WHR) in adults. Methods: Relevant studies, published up to August 2019, were searched through PubMed/Medline, Scopus, ISI Web of Science, Embase and Google Scholar. All randomized clinical trials investigating the effect of berberine and barberry on the anthropometric measures including BMI, BW, WC or/and WHR were included. Results: Out of 252 citations, 12 trials that enrolled 849 subjects were included. Berberine and barberry resulted in no significant change in BMI (Weighted mean differences (WMD): -0.16 kg/m(2); 95 % CI: -0.43 to 0.11, P = 0.247), BW (WMD: -0.11 kg; 95 % CI: -0.13 to 0.91, P = 0.830), and berberine resulted in not significant in WC (WMD:-0.58 cm; 95 % CI:-1.89 to 0.72, P= 0.379) and significant reduction in WHR (WMD: -0.03; 95 % CI: -0.04 to -0.01, P< 0.0001). Conclusion: We found a significant reduction in WHR following berberine consumption in adults. Further clinical trials with high quality according to challenges mentioned seem to be helpful to use berberine and barberry as a supplement for certain health conditions, efficiently.
引用
收藏
页数:8
相关论文
共 49 条
[1]   In vitro biological assessment of berberis vulgaris and its active constituent, berberine: Antioxidants, anti-acetylcholinesterase, anti-diabetic and anticancer effects [J].
Abd El-Wahab A.E. ;
Ghareeb D.A. ;
Sarhan E.E.M. ;
Abu-Serie M.M. ;
El Demellawy M.A. .
BMC Complementary and Alternative Medicine, 13 (1)
[2]   The use of berberine for women with polycystic ovary syndrome undergoing IVF treatment [J].
An, Yuan ;
Sun, Zhuangzhuang ;
Zhang, Yajuan ;
Liu, Bin ;
Guan, Yuanyuan ;
Lu, Meisong .
CLINICAL ENDOCRINOLOGY, 2014, 80 (03) :425-431
[3]  
[Anonymous], IJEM
[4]  
[Anonymous], 2015, Nutrafoods, DOI DOI 10.1007/S13749-015-0052-7
[5]  
Birdsall T. C., 1997, Alternative Medicine Review, V2, P94
[6]   c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-γ1 and negatively regulates its transcriptional activity [J].
Camp, HS ;
Tafuri, SR ;
Leff, T .
ENDOCRINOLOGY, 1999, 140 (01) :392-397
[7]   Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease [J].
Chang, Xinxia ;
Wang, Zhe ;
Zhang, Jinlan ;
Yan, Hongmei ;
Bian, Hua ;
Xia, Mingfeng ;
Lin, Huandong ;
Jiang, Jiandong ;
Gao, Xin .
JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14
[8]   The role of a fixed Berberis aristata/Silybum marianum combination in the treatment of type 1 diabetes mellitus [J].
Derosa, Giuseppe ;
D'Angelo, Angela ;
Maffioli, Pamela .
CLINICAL NUTRITION, 2016, 35 (05) :1091-1095
[9]   Berberis aristata/Silybum marianum fixed combination (Berberol®) effects on lipid profile in dyslipidemic patients intolerant to statins at high dosages: A randomized, placebo-controlled, clinical trial [J].
Derosa, Giuseppe ;
Romano, Davide ;
D'Angelo, Angela ;
Maffioli, Pamela .
PHYTOMEDICINE, 2015, 22 (02) :231-237
[10]   Berberis aristata combined with Silybum marianum on lipid profile in patients not tolerating statins at high doses [J].
Derosa, Giuseppe ;
Romano, Davide ;
D'Angelo, Angela ;
Maffioli, Pamela .
ATHEROSCLEROSIS, 2015, 239 (01) :87-92